中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
25期
147-148
,共2页
海昆肾喜胶囊%慢性肾功能衰竭%临床疗效
海昆腎喜膠囊%慢性腎功能衰竭%臨床療效
해곤신희효낭%만성신공능쇠갈%림상료효
Haikunshenxi capsule%Chronic renal failure%Clinical efficacy
目的：分析海昆肾喜胶囊辅助治疗慢性肾功能衰竭的临床疗效。方法76例慢性肾功能衰竭随机分为实验组和对照组。实验组采用海昆肾喜胶囊治疗，对照组采用百令胶囊治疗，对比两组患者治疗前后临床疗效。结果实验组治疗后的Scr、BUN、mALB低于对照组，而实验组治疗后的Hb、Alb高于对照组，TG、TC低于对照组，差异均具有统计学意义（P<0.05）。结论海昆肾喜胶囊辅助治疗CRF临床疗效优于百令胶囊。
目的：分析海昆腎喜膠囊輔助治療慢性腎功能衰竭的臨床療效。方法76例慢性腎功能衰竭隨機分為實驗組和對照組。實驗組採用海昆腎喜膠囊治療，對照組採用百令膠囊治療，對比兩組患者治療前後臨床療效。結果實驗組治療後的Scr、BUN、mALB低于對照組，而實驗組治療後的Hb、Alb高于對照組，TG、TC低于對照組，差異均具有統計學意義（P<0.05）。結論海昆腎喜膠囊輔助治療CRF臨床療效優于百令膠囊。
목적：분석해곤신희효낭보조치료만성신공능쇠갈적림상료효。방법76례만성신공능쇠갈수궤분위실험조화대조조。실험조채용해곤신희효낭치료，대조조채용백령효낭치료，대비량조환자치료전후림상료효。결과실험조치료후적Scr、BUN、mALB저우대조조，이실험조치료후적Hb、Alb고우대조조，TG、TC저우대조조，차이균구유통계학의의（P<0.05）。결론해곤신희효낭보조치료CRF림상료효우우백령효낭。
Objective To analyze the clinical efficacy of haikunshenxi capsule adjuvant treatment for chronic renal failure(CRF). Methods 76 CRF patients were randomly divided into experimental and control groups,experimental group received haikunshenxi capsules and control group accepted bailing capsule,the clinical efficacy in two groups of patients were compared before and after treatment. Results After treatment,Scr,BUN and mALB of experimental group were significantly lower than control group,while Hb and Alb of experimental group were higher than control group,the TG and TC were significantly lower than control group,difference al had statistical significance(P< 0.05). Conclusion The clinical efficacy of haikunshenxi capsule adjuvant therapy for CRF is significantly better than bailing capsule.
